371 related articles for article (PubMed ID: 34503454)
1. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.
Li M; Deng L; Xu G
Mol Med; 2021 Sep; 27(1):106. PubMed ID: 34503454
[TBL] [Abstract][Full Text] [Related]
2. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.
Wang Q; Ren D; Li Y; Xu G
Cell Cycle; 2019; 18(6-7):696-707. PubMed ID: 30784349
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 mediates high glucose-induced glomerular endothelial cell injury by epigenetically inhibiting klotho via methyltransferase G9a.
Li Y; Ren D; Xu G
IUBMB Life; 2019 Jul; 71(7):873-881. PubMed ID: 30762931
[TBL] [Abstract][Full Text] [Related]
4. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.
Jian D; Wang Y; Jian L; Tang H; Rao L; Chen K; Jia Z; Zhang W; Liu Y; Chen X; Shen X; Gao C; Wang S; Li M
Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173
[No Abstract] [Full Text] [Related]
5. METTL14 aggravates podocyte injury and glomerulopathy progression through N
Lu Z; Liu H; Song N; Liang Y; Zhu J; Chen J; Ning Y; Hu J; Fang Y; Teng J; Zou J; Dai Y; Ding X
Cell Death Dis; 2021 Sep; 12(10):881. PubMed ID: 34580283
[TBL] [Abstract][Full Text] [Related]
6. METTL3-mediated m
Jiang L; Liu X; Hu X; Gao L; Zeng H; Wang X; Huang Y; Zhu W; Wang J; Wen J; Meng X; Wu Y
Mol Ther; 2022 Apr; 30(4):1721-1740. PubMed ID: 34995800
[TBL] [Abstract][Full Text] [Related]
7. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
Kadoya H; Satoh M; Haruna Y; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Oct; 20(5):671-678. PubMed ID: 26586006
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of METTL14 mediates the elevation of PERP mRNA N
Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
[TBL] [Abstract][Full Text] [Related]
9. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
10. LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.
Wang ZB; Zhang S; Li Y; Wang RM; Tong LC; Wang Y; Liu WY; Su DF; Tu Y; Zhang LC; Li L
Acta Pharmacol Sin; 2017 Jul; 38(7):1009-1023. PubMed ID: 28414198
[TBL] [Abstract][Full Text] [Related]
11. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury.
Huang Y; Liu Y; Li L; Su B; Yang L; Fan W; Yin Q; Chen L; Cui T; Zhang J; Lu Y; Cheng J; Fu P; Liu F
BMC Nephrol; 2014 Sep; 15():142. PubMed ID: 25182190
[TBL] [Abstract][Full Text] [Related]
12. Advanced oxidation protein products induce endothelial-to-mesenchymal transition in human renal glomerular endothelial cells through induction of endoplasmic reticulum stress.
Liang X; Duan N; Wang Y; Shu S; Xiang X; Guo T; Yang L; Zhang S; Tang X; Zhang J
J Diabetes Complications; 2016; 30(4):573-9. PubMed ID: 26861949
[TBL] [Abstract][Full Text] [Related]
13. METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate.
Chen J; Ning Y; Zhang H; Song N; Gu Y; Shi Y; Cai J; Ding X; Zhang X
Life Sci; 2019 Dec; 239():117034. PubMed ID: 31697949
[TBL] [Abstract][Full Text] [Related]
14. Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis.
Bai Y; Huang L; Fan Y; Li Y
FASEB J; 2024 Jun; 38(11):e23729. PubMed ID: 38847786
[TBL] [Abstract][Full Text] [Related]
15. METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis.
He M; Lei H; He X; Liu Y; Wang A; Ren Z; Liu X; Yan G; Wang W; Wang Y; Li G; Wang T; Pu J; Shen Z; Wang Y; Xie J; Du W; Yuan Y; Yang L
Stem Cells Transl Med; 2022 Sep; 11(9):987-1001. PubMed ID: 35980318
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin protects renal glomerular endothelial cells against high glucose-induced dysfunction and injury.
Xu L; Shao F
Bioengineered; 2022 Jan; 13(1):655-666. PubMed ID: 34967261
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
18. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.
Xu Y; Yuan XD; Wu JJ; Chen RY; Xia L; Zhang M; Han CH; Mou S
J Cell Biochem; 2020 Jan; 121(1):524-533. PubMed ID: 31318098
[TBL] [Abstract][Full Text] [Related]
19. METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.
Xu Z; Jia K; Wang H; Gao F; Zhao S; Li F; Hao J
Cell Death Dis; 2021 Jan; 12(1):32. PubMed ID: 33414476
[TBL] [Abstract][Full Text] [Related]
20. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
